FEEGQUOZOCUHBZ-UHFFFAOYSA-N
C38H32F3N5O — CID 162618270
Data last refreshed: (MolForge compound catalog, from PubChem)
About FEEGQUOZOCUHBZ-UHFFFAOYSA-N
FEEGQUOZOCUHBZ-UHFFFAOYSA-N (PubChem CID 162618270) has the molecular formula C38H32F3N5O and a molecular weight of 631.70 g/mol. Its IUPAC name is 1-(3-cyano-6-methylcyclohexa-2,4-dien-1-yl)-N-[3-[(cyclopropylmethylamino)-phenanthren-9-ylmethyl]phenyl]-3-(trifluoromethyl)pyrazole-5-carboxamide.
Molecular Properties
| Compound Name | FEEGQUOZOCUHBZ-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 162618270 |
| Molecular Formula | C38H32F3N5O |
| Molecular Weight | 631.70 g/mol |
| Exact Mass | 631.26 |
| IUPAC Name | 1-(3-cyano-6-methylcyclohexa-2,4-dien-1-yl)-N-[3-[(cyclopropylmethylamino)-phenanthren-9-ylmethyl]phenyl]-3-(trifluoromethyl)pyrazole-5-carboxamide |
| SMILES | CC1C=CC(C#N)=CC1n1nc(C(F)(F)F)cc1C(=O)Nc1cccc(C(NCC2CC2)c2cc3ccccc3c3ccccc23)c1 |
| InChI | InChI=1S/C38H32F3N5O/c1-23-13-14-25(21-42)17-33(23)46-34(20-35(45-46)38(39,40)41)37(47)44-28-9-6-8-27(18-28)36(43-22-24-15-16-24)32-19-26-7-2-3-10-29(26)30-11-4-5-12-31(30)32/h2-14,17-20,23-24,33,36,43H,15-16,22H2,1H3,(H,44,47) |
| InChIKey | FEEGQUOZOCUHBZ-UHFFFAOYSA-N |
| XLogP | 8.75 |
| TPSA | 82.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 631.70 |
| LogP ≤ 5 | 8.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162618270 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.